A systematic overview of radiation therapy effects in cervical cancer (Cervix uteri)

Acta Oncologica

Volumn 42, Issue 5-6, 2003, Pages 546-556

  Einhorn, Nina ^a   Tropé, Claes ^b   Ridderheim, Mona ^c   Boman, Karin ^d   Sorbe, Bengt ^e   Cavallin Ståhl, Eva ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e Orebro Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DISEASES; DRUG DOSAGE; TUMORS;

CERVICAL CANCER;

RADIOTHERAPY;

BLEOMYCIN; CISPLATIN; EPIRUBICIN; FLUOROURACIL; HYDROXYUREA; MITOMYCIN; VINCRISTINE;

BEAM THERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; HUMAN; HYSTERECTOMY; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; META ANALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZATION; REVIEW; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0141636527     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310014660     Document Type: Review

References (35)

1. Sundfor K, Trope CG, Hogberg T, et al. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996; 77: 2371-8 (C3/94).
2. Lahousen M, Haas J, Pickel H, et al. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial. Gynecol Oncol 1999; 73: 196-201 (C3/76).
3. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-40 (C1/343).
4. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis. Lancet 2001; 358: 781-6 (M1/3611).
5. Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995; 274: 387-93 (C1/367).
6. Viswanathan FR, Varghese C, Peedicayil A, et al. Hyperfractionation in carcinoma of the cervix: tumor control and late bowel complications. Int J Radiat Oncol Biol Phys 1999; 45: 653-6 (C3/30).
7. Leborgne F, Leborgne JH, Doldan R, et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997; 37: 343-50 (C3/96).
8. Sundfor K, Trope CG, Kjorstad KE. Radical radiotherapy versus brachytherapy plus surgery in carcinoma of the cervix 2A and 2B-long-term results from a randomized study 1968-1980. Acta Oncol 1996; 35(Suppl 8): 99-107 (C2/142).
9. Kumar L, Kaushal R, Nandy M, et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 1994; 54: 307-15 (C2/177).
10. Chiara S, Bruzzone M, Merlini L, et al. Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group). Am J Clin Oncol 1994; 17:294-7 (C3/64).
11. Thomas G, Dembo A, Ackerman I, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer. Gynecol Oncol 1998; 69: 137-45 (C3/221).
12. Patel FD, Sharma SC, Negi PS, et al. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1994; 28: 335-41 (C1/482).
13. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73: 177-83 (C1/277).
14. Curtin JP, Hoskins WJ, Venkatraman ES, et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol 1996; 61: 3-10 (C3/99).
15. Onishi H, Yamaguchi M, Kuriyama K, et al. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy. Cancer J Sci Am 2000; 6: 40-5 (C3/33).
16. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-61 (C1/369).
17. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43 (C1/388).
18. Tseng CJ, Chang CT, Lai CH, et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol 1997; 66: 52-8 (C3/122).
19. Peters III WA, Liu PY, Barrett II RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-13 (C1/243).
20. Pearcey R. Plat. RT versus RT in advanced cervix cancer. Proc ASCO Ann Meeting New Orleans, LA 2000: Abstr 1497.
21. Wong LC, Ngan HY, Cheung AN, et al. Chemoradiation and adjuvant chemotherapy in cervical cancer. J Clin Oncol 1999; 17: 2055-60 (C3/220).
22. Lorvidhaya V, Tonusin A, Sukthomya W, et al. Induction chemotherapy and irradiation in advanced carcinoma of the cervix. Gan To Kagaku Ryoho 1995; 22(Suppl 3): 244-51 (C3/673).
23. Tattersall MH, Lorvidhaya V, Vootiprux V, et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. J Clin Oncol 1995; 13: 444-51 (C1/260).
24. Sardi J, Giaroli A, Sananes C, et al. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma cervix uteri: an unexpected therapeutic management. Int J Gynecol Cancer 1996; 6: 85-93 (C3/155).
25. Chatani M, Matayoshi Y, Masaki N, et al. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol 1995; 171: 655-60 (C2/93).
26. Patel FD, Negi PS, Sharma SC, et al. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix. Radiother Oncol 1998; 49: 317-23 (C2/180).
27. el-Baradie M, Inoue T, Murayama S, et al. HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol 1997; 173: 155-62 (C2/45).
28. Chatani M, Matayoshi Y, Masaki N, et al. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results. Strahlenther Onkol 1994; 170: 636 42 (C1/165).
29. Haie-Meder C, Kramar A, Lambin P, et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 1994; 29: 953-60 (C3/204).
30. Lambin P, Gerbaulet A, Kramar A, et al. A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trial. Eur J Cancer 1994; 30A: 312-20 (C3/155).
31. Dische S, Saunders MI, Scaly R, et al. Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial. Radiother Oncol 1999; 53: 93-8 (C3/327).
32. Grigsby PW, Winter K, Wasserman TH, et al. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1999; 44: 513-7 (C2/128).
33. Okkan S, Atkovar G, Sahinler I, et al. A randomised study of ornidazole as a radiosensitiser in carcinoma of the cervix: long term results. Br J Cancer; (Suppl 1996; 27): S282-6 (C3/76).
34. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53 (C2/526).
35. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic: lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999; 17: 1339-48 (C2/368).